US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems
July 01, 2024 04:30 ET
|
Nexstim Oyj
Press release, Helsinki, 1 July 2024 at 11:30 AM (EEST) US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that it has received...
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024 09:05 ET
|
ResMed Inc.
ResMed-supported research presented at SLEEP2024 demonstrates the effectiveness and value of positive airway pressure (PAP) treatment for OSA.
Distributor Orders Nexstim NBS System 5 for European Hospital
June 10, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 10 June 2024 at 9 AM (EEST) Distributor Orders Nexstim NBS System 5 for European Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS...
New study identifies higher risk of depression and anxiety among young men, gay or bisexual, and racialized Canadian men
May 30, 2024 08:00 ET
|
Canadian Men's Health Foundation
National study from the Canadian Men’s Health Foundation released for Men’s Health Month in June.
Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression
May 20, 2024 07:45 ET
|
Clearlight® — Infrared Saunas and Wellness Solutions
Berkeley, California, May 20, 2024 (GLOBE NEWSWIRE) -- In conjunction with May as Mental Health Awareness Month, preliminary results from a University of California, San Francisco (UCSF) clinical...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
May 09, 2024 09:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Finnish Hospital Orders Nexstim NBS System 5
May 08, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024 07:00 ET
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Pacific Clinics Announces 100 Job Openings in Bay Area
April 25, 2024 16:42 ET
|
Pacific Clinics
Campbell, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Pacific Clinics, California’s leading provider of community-based mental health and substance use services, has more than 100 open job positions...
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
April 23, 2024 08:15 ET
|
Silo Pharma, Inc.
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”),...